USA MRSA Drugs Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA MRSA Drugs market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA MRSA Drugs market. Detailed analysis of key players, along with key growth strategies adopted by MRSA Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Cempra

    • Allergan

    • Debiopharm

    • CrystalGenomics

    • Pfizer

    • AstraZeneca

    • Lytix Biopharma

    • Merck

    • Melinta Therapeutics

    • Galapagos

    • Basilea Pharmaceutica

    • Cellceutix

    • Nabriva Therapeutics

    • Baxter

    • GSK

    • Theravance Biopharma

    • NovaDigm Therapeutics

    • Absynth Biologics

    • KYORIN Pharmaceutical

    • AmpliPhi Biosciences

    By Type:

    • Tetracycline

    • Folate antagonist

    • Cephalosporin

    • Lipopeptides

    • Oxazolidinone

    • Lipoglycopeptide

    By End-User:

    • Hospital

    • Research

    • Clinic

    • Other

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of MRSA Drugs Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA MRSA Drugs Market Size and Growth Rate of Tetracycline from 2016 to 2027

      • 1.3.2 USA MRSA Drugs Market Size and Growth Rate of Folate antagonist from 2016 to 2027

      • 1.3.3 USA MRSA Drugs Market Size and Growth Rate of Cephalosporin from 2016 to 2027

      • 1.3.4 USA MRSA Drugs Market Size and Growth Rate of Lipopeptides from 2016 to 2027

      • 1.3.5 USA MRSA Drugs Market Size and Growth Rate of Oxazolidinone from 2016 to 2027

      • 1.3.6 USA MRSA Drugs Market Size and Growth Rate of Lipoglycopeptide from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA MRSA Drugs Market Size and Growth Rate of Hospital from 2016 to 2027

      • 1.4.2 USA MRSA Drugs Market Size and Growth Rate of Research from 2016 to 2027

      • 1.4.3 USA MRSA Drugs Market Size and Growth Rate of Clinic from 2016 to 2027

      • 1.4.4 USA MRSA Drugs Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA MRSA Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA MRSA Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA MRSA Drugs Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA MRSA Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of MRSA Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of MRSA Drugs by Major Types

      • 3.4.1 Market Size and Growth Rate of Tetracycline

      • 3.4.2 Market Size and Growth Rate of Folate antagonist

      • 3.4.3 Market Size and Growth Rate of Cephalosporin

      • 3.4.4 Market Size and Growth Rate of Lipopeptides

      • 3.4.5 Market Size and Growth Rate of Oxazolidinone

      • 3.4.6 Market Size and Growth Rate of Lipoglycopeptide

    4 Segmentation of MRSA Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of MRSA Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of MRSA Drugs in Hospital

      • 4.4.2 Market Size and Growth Rate of MRSA Drugs in Research

      • 4.4.3 Market Size and Growth Rate of MRSA Drugs in Clinic

      • 4.4.4 Market Size and Growth Rate of MRSA Drugs in Other

    5 Market Analysis by Regions

    • 5.1 USA MRSA Drugs Production Analysis by Regions

    • 5.2 USA MRSA Drugs Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA MRSA Drugs Landscape Analysis

    • 6.1 West USA MRSA Drugs Landscape Analysis by Major Types

    • 6.2 West USA MRSA Drugs Landscape Analysis by Major End-Users

    7 South USA MRSA Drugs Landscape Analysis

    • 7.1 South USA MRSA Drugs Landscape Analysis by Major Types

    • 7.2 South USA MRSA Drugs Landscape Analysis by Major End-Users

    8 Middle West USA MRSA Drugs Landscape Analysis

    • 8.1 Middle West USA MRSA Drugs Landscape Analysis by Major Types

    • 8.2 Middle West USA MRSA Drugs Landscape Analysis by Major End-Users

    9 Northeast USA MRSA Drugs Landscape Analysis

    • 9.1 Northeast USA MRSA Drugs Landscape Analysis by Major Types

    • 9.2 Northeast USA MRSA Drugs Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Cempra

        • 10.1.1 Cempra Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Allergan

        • 10.2.1 Allergan Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Debiopharm

        • 10.3.1 Debiopharm Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 CrystalGenomics

        • 10.4.1 CrystalGenomics Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Pfizer

        • 10.5.1 Pfizer Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 AstraZeneca

        • 10.6.1 AstraZeneca Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Lytix Biopharma

        • 10.7.1 Lytix Biopharma Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Merck

        • 10.8.1 Merck Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Melinta Therapeutics

        • 10.9.1 Melinta Therapeutics Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Galapagos

        • 10.10.1 Galapagos Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Basilea Pharmaceutica

        • 10.11.1 Basilea Pharmaceutica Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Cellceutix

        • 10.12.1 Cellceutix Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 Nabriva Therapeutics

        • 10.13.1 Nabriva Therapeutics Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

      • 10.14 Baxter

        • 10.14.1 Baxter Company Profile and Recent Development

        • 10.14.2 Market Performance

        • 10.14.3 Product and Service Introduction

      • 10.15 GSK

        • 10.15.1 GSK Company Profile and Recent Development

        • 10.15.2 Market Performance

        • 10.15.3 Product and Service Introduction

      • 10.16 Theravance Biopharma

        • 10.16.1 Theravance Biopharma Company Profile and Recent Development

        • 10.16.2 Market Performance

        • 10.16.3 Product and Service Introduction

      • 10.17 NovaDigm Therapeutics

        • 10.17.1 NovaDigm Therapeutics Company Profile and Recent Development

        • 10.17.2 Market Performance

        • 10.17.3 Product and Service Introduction

      • 10.18 Absynth Biologics

        • 10.18.1 Absynth Biologics Company Profile and Recent Development

        • 10.18.2 Market Performance

        • 10.18.3 Product and Service Introduction

      • 10.19 KYORIN Pharmaceutical

        • 10.19.1 KYORIN Pharmaceutical Company Profile and Recent Development

        • 10.19.2 Market Performance

        • 10.19.3 Product and Service Introduction

      • 10.20 AmpliPhi Biosciences

        • 10.20.1 AmpliPhi Biosciences Company Profile and Recent Development

        • 10.20.2 Market Performance

        • 10.20.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA MRSA Drugs Market Size and Growth Rate of Tetracycline from 2016 to 2027

    • Figure USA MRSA Drugs Market Size and Growth Rate of Folate antagonist from 2016 to 2027

    • Figure USA MRSA Drugs Market Size and Growth Rate of Cephalosporin from 2016 to 2027

    • Figure USA MRSA Drugs Market Size and Growth Rate of Lipopeptides from 2016 to 2027

    • Figure USA MRSA Drugs Market Size and Growth Rate of Oxazolidinone from 2016 to 2027

    • Figure USA MRSA Drugs Market Size and Growth Rate of Lipoglycopeptide from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA MRSA Drugs Market Size and Growth Rate of Hospital from 2016 to 2027

    • Figure USA MRSA Drugs Market Size and Growth Rate of Research from 2016 to 2027

    • Figure USA MRSA Drugs Market Size and Growth Rate of Clinic from 2016 to 2027

    • Figure USA MRSA Drugs Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA MRSA Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA MRSA Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA MRSA Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA MRSA Drugs Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of MRSA Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of MRSA Drugs

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of MRSA Drugs by Different Types from 2016 to 2027

    • Table Consumption Share of MRSA Drugs by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Tetracycline

    • Figure Market Size and Growth Rate of Folate antagonist

    • Figure Market Size and Growth Rate of Cephalosporin

    • Figure Market Size and Growth Rate of Lipopeptides

    • Figure Market Size and Growth Rate of Oxazolidinone

    • Figure Market Size and Growth Rate of Lipoglycopeptide

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of MRSA Drugs by Different End-Users from 2016 to 2027

    • Table Consumption Share of MRSA Drugs by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Research

    • Figure Market Size and Growth Rate of Clinic

    • Figure Market Size and Growth Rate of Other

    • Table USA MRSA Drugs Production by Regions

    • Table USA MRSA Drugs Production Share by Regions

    • Figure USA MRSA Drugs Production Share by Regions in 2016

    • Figure USA MRSA Drugs Production Share by Regions in 2021

    • Figure USA MRSA Drugs Production Share by Regions in 2027

    • Table USA MRSA Drugs Consumption by Regions

    • Table USA MRSA Drugs Consumption Share by Regions

    • Figure USA MRSA Drugs Consumption Share by Regions in 2016

    • Figure USA MRSA Drugs Consumption Share by Regions in 2021

    • Figure USA MRSA Drugs Consumption Share by Regions in 2027

    • Table West USA MRSA Drugs Consumption by Types from 2016 to 2027

    • Table West USA MRSA Drugs Consumption Share by Types from 2016 to 2027

    • Figure West USA MRSA Drugs Consumption Share by Types in 2016

    • Figure West USA MRSA Drugs Consumption Share by Types in 2021

    • Figure West USA MRSA Drugs Consumption Share by Types in 2027

    • Table West USA MRSA Drugs Consumption by End-Users from 2016 to 2027

    • Table West USA MRSA Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure West USA MRSA Drugs Consumption Share by End-Users in 2016

    • Figure West USA MRSA Drugs Consumption Share by End-Users in 2021

    • Figure West USA MRSA Drugs Consumption Share by End-Users in 2027

    • Table South USA MRSA Drugs Consumption by Types from 2016 to 2027

    • Table South USA MRSA Drugs Consumption Share by Types from 2016 to 2027

    • Figure South USA MRSA Drugs Consumption Share by Types in 2016

    • Figure South USA MRSA Drugs Consumption Share by Types in 2021

    • Figure South USA MRSA Drugs Consumption Share by Types in 2027

    • Table South USA MRSA Drugs Consumption by End-Users from 2016 to 2027

    • Table South USA MRSA Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure South USA MRSA Drugs Consumption Share by End-Users in 2016

    • Figure South USA MRSA Drugs Consumption Share by End-Users in 2021

    • Figure South USA MRSA Drugs Consumption Share by End-Users in 2027

    • Table Middle West USA MRSA Drugs Consumption by Types from 2016 to 2027

    • Table Middle West USA MRSA Drugs Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA MRSA Drugs Consumption Share by Types in 2016

    • Figure Middle West USA MRSA Drugs Consumption Share by Types in 2021

    • Figure Middle West USA MRSA Drugs Consumption Share by Types in 2027

    • Table Middle West USA MRSA Drugs Consumption by End-Users from 2016 to 2027

    • Table Middle West USA MRSA Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA MRSA Drugs Consumption Share by End-Users in 2016

    • Figure Middle West USA MRSA Drugs Consumption Share by End-Users in 2021

    • Figure Middle West USA MRSA Drugs Consumption Share by End-Users in 2027

    • Table Northeast USA MRSA Drugs Consumption by Types from 2016 to 2027

    • Table Northeast USA MRSA Drugs Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA MRSA Drugs Consumption Share by Types in 2016

    • Figure Northeast USA MRSA Drugs Consumption Share by Types in 2021

    • Figure Northeast USA MRSA Drugs Consumption Share by Types in 2027

    • Table Northeast USA MRSA Drugs Consumption by End-Users from 2016 to 2027

    • Table Northeast USA MRSA Drugs Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA MRSA Drugs Consumption Share by End-Users in 2016

    • Figure Northeast USA MRSA Drugs Consumption Share by End-Users in 2021

    • Figure Northeast USA MRSA Drugs Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Cempra

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cempra

    • Figure Sales and Growth Rate Analysis of Cempra

    • Figure Revenue and Market Share Analysis of Cempra

    • Table Product and Service Introduction of Cempra

    • Table Company Profile and Development Status of Allergan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

    • Figure Sales and Growth Rate Analysis of Allergan

    • Figure Revenue and Market Share Analysis of Allergan

    • Table Product and Service Introduction of Allergan

    • Table Company Profile and Development Status of Debiopharm

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Debiopharm

    • Figure Sales and Growth Rate Analysis of Debiopharm

    • Figure Revenue and Market Share Analysis of Debiopharm

    • Table Product and Service Introduction of Debiopharm

    • Table Company Profile and Development Status of CrystalGenomics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CrystalGenomics

    • Figure Sales and Growth Rate Analysis of CrystalGenomics

    • Figure Revenue and Market Share Analysis of CrystalGenomics

    • Table Product and Service Introduction of CrystalGenomics

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Lytix Biopharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lytix Biopharma

    • Figure Sales and Growth Rate Analysis of Lytix Biopharma

    • Figure Revenue and Market Share Analysis of Lytix Biopharma

    • Table Product and Service Introduction of Lytix Biopharma

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Melinta Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Melinta Therapeutics

    • Figure Sales and Growth Rate Analysis of Melinta Therapeutics

    • Figure Revenue and Market Share Analysis of Melinta Therapeutics

    • Table Product and Service Introduction of Melinta Therapeutics

    • Table Company Profile and Development Status of Galapagos

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Galapagos

    • Figure Sales and Growth Rate Analysis of Galapagos

    • Figure Revenue and Market Share Analysis of Galapagos

    • Table Product and Service Introduction of Galapagos

    • Table Company Profile and Development Status of Basilea Pharmaceutica

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Basilea Pharmaceutica

    • Figure Sales and Growth Rate Analysis of Basilea Pharmaceutica

    • Figure Revenue and Market Share Analysis of Basilea Pharmaceutica

    • Table Product and Service Introduction of Basilea Pharmaceutica

    • Table Company Profile and Development Status of Cellceutix

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cellceutix

    • Figure Sales and Growth Rate Analysis of Cellceutix

    • Figure Revenue and Market Share Analysis of Cellceutix

    • Table Product and Service Introduction of Cellceutix

    • Table Company Profile and Development Status of Nabriva Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nabriva Therapeutics

    • Figure Sales and Growth Rate Analysis of Nabriva Therapeutics

    • Figure Revenue and Market Share Analysis of Nabriva Therapeutics

    • Table Product and Service Introduction of Nabriva Therapeutics

    • Table Company Profile and Development Status of Baxter

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter

    • Figure Sales and Growth Rate Analysis of Baxter

    • Figure Revenue and Market Share Analysis of Baxter

    • Table Product and Service Introduction of Baxter

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of Theravance Biopharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Theravance Biopharma

    • Figure Sales and Growth Rate Analysis of Theravance Biopharma

    • Figure Revenue and Market Share Analysis of Theravance Biopharma

    • Table Product and Service Introduction of Theravance Biopharma

    • Table Company Profile and Development Status of NovaDigm Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NovaDigm Therapeutics

    • Figure Sales and Growth Rate Analysis of NovaDigm Therapeutics

    • Figure Revenue and Market Share Analysis of NovaDigm Therapeutics

    • Table Product and Service Introduction of NovaDigm Therapeutics

    • Table Company Profile and Development Status of Absynth Biologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Absynth Biologics

    • Figure Sales and Growth Rate Analysis of Absynth Biologics

    • Figure Revenue and Market Share Analysis of Absynth Biologics

    • Table Product and Service Introduction of Absynth Biologics

    • Table Company Profile and Development Status of KYORIN Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of KYORIN Pharmaceutical

    • Figure Sales and Growth Rate Analysis of KYORIN Pharmaceutical

    • Figure Revenue and Market Share Analysis of KYORIN Pharmaceutical

    • Table Product and Service Introduction of KYORIN Pharmaceutical

    • Table Company Profile and Development Status of AmpliPhi Biosciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AmpliPhi Biosciences

    • Figure Sales and Growth Rate Analysis of AmpliPhi Biosciences

    • Figure Revenue and Market Share Analysis of AmpliPhi Biosciences

    • Table Product and Service Introduction of AmpliPhi Biosciences


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.